Alzheimer’s Drug Development: Not An Easy Path To Pursue
Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on February 7, 2023
Anavex Strengthens Scientific Advisory Board with Investigator from Phase 2b/3 Alzheimer’s Trial
Anavex Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
